• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤相关的转化生长因子-β 亚型表达

Melanoma-associated expression of transforming growth factor-beta isoforms.

作者信息

Van Belle P, Rodeck U, Nuamah I, Halpern A C, Elder D E

机构信息

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia 19104, USA.

出版信息

Am J Pathol. 1996 Jun;148(6):1887-94.

PMID:8669474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1861638/
Abstract

Melanocytic neoplasia is characterized by the aberrant overproduction of multiple cytokines in vitro. However, it is largely unknown how cytokine expression relates to melanoma progression in vivo. Transforming growth factor beta (TGF-beta) is a multifunctional cytokine commonly produced by cultured melanoma cells. The in situ expression of all three TGF-beta isoforms (TGF-beta1, -2, and -3) was determined immunohistochemically in melanocytes and in 51 melanocytic lesions using isoform-specific antibodies. Significant linear trends of expression were observed from melanocytes through nevi and primary and metastatic melanomas for all three isoforms. TGF-beta1 was expressed by some melanocytes and almost uniformly by nevi and melanomas. TGF-beta2 and -3 were not expressed in normal melanocytes but were expressed in nevi and early and advanced primary (radial and vertical growth phase) and metastatic melanomas in a tumor-progression-related manner. TGF-beta2 was heterogeneously expressed in advanced primary and metastatic melanomas, whereas TGF-beta3 was uniformly and highly expressed in these lesions. Thus, expression of TGF-beta isoforms in melanocytes and melanocytic lesions is heterogeneous and related to tumor progression, and expression of TGF-beta2 and TGF-beta3 commences at critical junctures during progression of nevi to primary melanomas.

摘要

黑素细胞肿瘤形成的特征是在体外多种细胞因子异常过量产生。然而,细胞因子表达与体内黑色素瘤进展之间的关系在很大程度上尚不清楚。转化生长因子β(TGF-β)是培养的黑色素瘤细胞通常产生的一种多功能细胞因子。使用同工型特异性抗体,通过免疫组织化学方法测定了黑素细胞和51个黑素细胞性病变中所有三种TGF-β同工型(TGF-β1、-2和-3)的原位表达。对于所有三种同工型,从黑素细胞到痣、原发性和转移性黑色素瘤均观察到显著的线性表达趋势。TGF-β1由一些黑素细胞表达,痣和黑色素瘤几乎均一表达。TGF-β2和-3在正常黑素细胞中不表达,但在痣以及早期和晚期原发性(放射状和垂直生长期)和转移性黑色素瘤中以与肿瘤进展相关的方式表达。TGF-β2在晚期原发性和转移性黑色素瘤中呈异质性表达,而TGF-β3在这些病变中呈均一性高表达。因此,TGF-β同工型在黑素细胞和黑素细胞性病变中的表达是异质性的,且与肿瘤进展相关,TGF-β2和TGF-β3的表达在痣向原发性黑色素瘤进展的关键节点开始。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/317c/1861638/2b308cddda76/amjpathol00042-0173-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/317c/1861638/73c2efd46a1a/amjpathol00042-0172-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/317c/1861638/2b308cddda76/amjpathol00042-0173-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/317c/1861638/73c2efd46a1a/amjpathol00042-0172-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/317c/1861638/2b308cddda76/amjpathol00042-0173-a.jpg

相似文献

1
Melanoma-associated expression of transforming growth factor-beta isoforms.黑色素瘤相关的转化生长因子-β 亚型表达
Am J Pathol. 1996 Jun;148(6):1887-94.
2
Desensitization of melanoma cells to autocrine TGF-beta isoforms.黑色素瘤细胞对自分泌转化生长因子-β 亚型的脱敏作用。
J Cell Physiol. 1999 Feb;178(2):179-87. doi: 10.1002/(SICI)1097-4652(199902)178:2<179::AID-JCP7>3.0.CO;2-5.
3
Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression.转化生长因子-β2在恶性黑色素瘤中的表达与肿瘤浸润深度相关。对肿瘤进展的影响。
Am J Pathol. 1994 Jul;145(1):97-104.
4
In situ expression of transforming growth factor beta is associated with melanoma progression and correlates with Ki67, HLA-DR and beta 3 integrin expression.
Melanoma Res. 1997 Aug;7(4):313-21. doi: 10.1097/00008390-199708000-00006.
5
Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.微管相关蛋白2在良性和恶性黑素细胞中的表达:对皮肤黑素瘤分化和进展的影响
Am J Pathol. 2001 Jun;158(6):2107-15. doi: 10.1016/S0002-9440(10)64682-2.
6
In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.恶性黑色素瘤中转化生长因子-β(TGF-β1、TGF-β2、TGF-β3)及转化生长因子-βⅡ型受体表达的原位分析
Carcinogenesis. 1995 Jul;16(7):1499-503. doi: 10.1093/carcin/16.7.1499.
7
Expression of the tumor suppressor gene product p16INK4 in benign and malignant melanocytic lesions.肿瘤抑制基因产物p16INK4在良性和恶性黑素细胞性病变中的表达
J Invest Dermatol. 1998 Jun;110(6):932-8. doi: 10.1046/j.1523-1747.1998.00211.x.
8
Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.人类黑素细胞痣和黑色素瘤肿瘤进展阶段的抗原特征
Cancer Res. 1989 Sep 15;49(18):5091-6.
9
Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions.人类黑素细胞病变进展过程中细胞因子网络的免疫组织化学证据。
Int J Cancer. 1999 Apr 20;84(2):160-8. doi: 10.1002/(sici)1097-0215(19990420)84:2<160::aid-ijc12>3.0.co;2-r.
10
Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.原癌基因c-kit在恶性黑色素瘤中的表达:随着肿瘤进展蛋白丢失。
Mod Pathol. 1997 Sep;10(9):939-44.

引用本文的文献

1
Davanat-Mimetic Galactomannan and Its Sulfated Derivative: Structure and Antitumor Effects against Melanoma.达瓦纳特模拟半乳甘露聚糖及其硫酸化衍生物:结构与对黑色素瘤的抗肿瘤作用
Biomacromolecules. 2025 Sep 8;26(9):5614-5632. doi: 10.1021/acs.biomac.5c00290. Epub 2025 Aug 21.
2
Melanoma-derived extracellular vesicles transfer proangiogenic factors.黑色素瘤来源的细胞外囊泡可传递促血管生成因子。
Oncol Res. 2025 Jan 16;33(2):245-262. doi: 10.32604/or.2024.055449. eCollection 2025.
3
The tumor immune microenvironment in primary cutaneous melanoma.

本文引用的文献

1
Factors, including transforming growth factor beta, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cells.包括转化生长因子β在内的多种因子在胶质母细胞瘤残留腔中释放,会损害贴壁淋巴因子激活的杀伤细胞的活性。
Cancer Immunol Immunother. 1993 Jun;36(6):409-16. doi: 10.1007/BF01742258.
2
Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent.肿瘤进展的教训:黑色素瘤的侵袭性放射状生长期很常见,无转移能力,且生长缓慢。
J Invest Dermatol. 1993 Mar;100(3):342S-345S. doi: 10.1111/1523-1747.ep12470248.
3
Increased transforming growth factor beta expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells.
原发性皮肤黑色素瘤中的肿瘤免疫微环境。
Arch Dermatol Res. 2025 Jan 18;317(1):273. doi: 10.1007/s00403-024-03758-8.
4
Impact of and Extracts on UVA-Irradiated on 3D Cultured Melanoma Cells: A Proteomic Insight.[具体植物名称1]和[具体植物名称2]提取物对三维培养的黑色素瘤细胞经UVA照射后的影响:蛋白质组学洞察
Cells. 2024 Nov 21;13(23):1934. doi: 10.3390/cells13231934.
5
A chronic signaling TGFb zebrafish reporter identifies immune response in melanoma.慢性信号 TGFb 斑马鱼报告基因可鉴定黑色素瘤中的免疫反应。
Elife. 2024 Jun 14;13:e83527. doi: 10.7554/eLife.83527.
6
HYDIN mutation status as a potential predictor of immune checkpoint inhibitor efficacy in melanoma.HYDIN 突变状态作为黑色素瘤免疫检查点抑制剂疗效的潜在预测指标。
Aging (Albany NY). 2023 Aug 17;15(16):7997-8012. doi: 10.18632/aging.204925.
7
Localized immune surveillance of primary melanoma in the skin deciphered through executable modeling.通过可执行建模解析皮肤原发性黑素瘤的局部免疫监测。
Sci Adv. 2023 Apr 14;9(15):eadd1992. doi: 10.1126/sciadv.add1992. Epub 2023 Apr 12.
8
Human Melanoma-Associated Mast Cells Display a Distinct Transcriptional Signature Characterized by an Upregulation of the Complement Component 3 That Correlates With Poor Prognosis.人类黑色素瘤相关肥大细胞表现出独特的转录特征,其特征是补体成分 3 的上调,这与预后不良相关。
Front Immunol. 2022 May 20;13:861545. doi: 10.3389/fimmu.2022.861545. eCollection 2022.
9
Melanoma secretion of transforming growth factor-β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration.黑素瘤分泌转化生长因子-β2 导致表皮 AMBRA1 丧失,威胁表皮完整性并促进肿瘤溃疡。
Br J Dermatol. 2022 Apr;186(4):694-704. doi: 10.1111/bjd.20889. Epub 2021 Dec 27.
10
CTLA-4 blockade and interferon-α induce proinflammatory transcriptional changes in the tumor immune landscape that correlate with pathologic response in melanoma.CTLA-4 阻断和干扰素-α 在肿瘤免疫图谱中诱导促炎转录变化,与黑色素瘤的病理反应相关。
PLoS One. 2021 Jan 11;16(1):e0245287. doi: 10.1371/journal.pone.0245287. eCollection 2021.
转化生长因子β表达增加在体外抑制细胞增殖,但却增强了Meth A肉瘤细胞的致瘤性和肿瘤生长。
Cancer Res. 1993 Sep 15;53(18):4391-8.
4
Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.正常人类黑素细胞和黑色素瘤细胞中转化生长因子β的产生及反应性
Cancer Res. 1994 Jan 15;54(2):575-81.
5
Expression of transforming growth factor beta mRNA isoforms in human breast cancer.转化生长因子β mRNA 亚型在人乳腺癌中的表达
Br J Cancer. 1994 Jun;69(6):1006-9. doi: 10.1038/bjc.1994.197.
6
Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression.转化生长因子-β2在恶性黑色素瘤中的表达与肿瘤浸润深度相关。对肿瘤进展的影响。
Am J Pathol. 1994 Jul;145(1):97-104.
7
Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.抗转化生长因子(TGF)-β抗体可抑制乳腺癌细胞的致瘤性,并增强小鼠脾脏自然杀伤细胞的活性。这暗示了肿瘤细胞/宿主TGF-β相互作用在人类乳腺癌进展中可能发挥的作用。
J Clin Invest. 1993 Dec;92(6):2569-76. doi: 10.1172/JCI116871.
8
A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.一项关于肿瘤进展的研究:浅表扩散型和结节型黑色素瘤的前驱病变
Hum Pathol. 1984 Dec;15(12):1147-65. doi: 10.1016/s0046-8177(84)80310-x.
9
T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta.来自人胶质母细胞瘤细胞的T细胞抑制因子是一种与转化生长因子-β密切相关的12.5千道尔顿蛋白质。
EMBO J. 1987 Jun;6(6):1633-6. doi: 10.1002/j.1460-2075.1987.tb02411.x.
10
Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family.人胶质母细胞瘤衍生的T细胞抑制因子的互补DNA,转化生长因子-β基因家族的一个新成员。
EMBO J. 1987 Dec 1;6(12):3673-7. doi: 10.1002/j.1460-2075.1987.tb02700.x.